Interview With RWE Expert on Expectations for FDA Framework

In a recent interview with The Evidence Base, real world evidence (RWE) expert Sreeram Ramagopalan shared his thoughts on the changing RWE landscape. He also discussed what the Food and Drug Administration (FDA) will—and won’t—include in its upcoming RWE guidelines.

“Our expert for this instalment is Sreeram Ramagopalan, Global Head of Real-World Evidence, Market Access, at F. Hoffmann-La Roche (Basel, Switzerland).” Read more here.

(Source: Sreeram Ramagopalan, The Evidence Base, 9/17/21)